Corpus Intelligence IC Memo — PROVIDENCE ST JOSEPHS HOSPITAL 2026-04-26 09:33 UTC
IC Memo — PROVIDENCE ST JOSEPHS HOSPITAL
Investment Committee Memorandum | WA | 23 beds | Grade C | EBITDA uplift $1.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PROVIDENCE ST JOSEPHS HOSPITAL

CCN 501309 | STEVENS, WA | 23 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

PROVIDENCE ST JOSEPHS HOSPITAL is a 23-bed rural/critical access in STEVENS, WA with $20.1M in net patient revenue and a -9.3% operating margin. The hospital serves a payer mix of 38.3% Medicare, 0.1% Medicaid, and 61.6% commercial.

Thesis: Turnaround. Our ML models identify $1.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -9.3% to -1.9% (+736bps).

Net Revenue HCRIS$20.1M
Current EBITDA COMPUTED$-1.9M
Operating Margin COMPUTED-9.3%
Occupancy HCRIS27.9%
Revenue / Bed COMPUTED$875K
Net-to-Gross HCRIS49.9%
Distress Probability ML55.1%

2. Market Context & Competitive Position

104
WA Hospitals
-10.3%
State Median Margin
39
Comparable Hospitals

WA has 104 Medicare-certified hospitals with a median operating margin of -10.3%. The target's margin of -9.3% places it above the state median. Among 39 size-comparable peers (12-46 beds), the median margin is -9.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-46), prioritizing same-state peers. 39 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PROVIDENCE ST JOSEPHS HOSPITAL (Target)WA23$20.1M-9.3%
FRED HUTCHINSON CANCER CENTERWA20$1.17B-50.0%
JEFFERSON GENERAL HOSPITALWA25$148.0M-3.0%
MASON GENERAL HOSPITALWA25$127.1M-5.3%
KITTITAS VALLEY COMMUNITY HOSPWA25$121.0M2.3%
TRI-STATE MEMORIAL HOSPITALWA25$107.0M0.8%
ISLAND HOSPITALWA43$106.1M-15.0%
ASTRIA SUNNYSIDE HOSPITALWA25$102.5M1.7%
WHIDBEY GENERAL HOSPITALWA25$98.0M-23.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$422K+210bp18mo
Cost to Collect4.5%2.5%$402K+200bp12mo
Denial Rate Reduction12.0%6.5%$398K+198bp12mo
A/R Days Reduction5200.0%3800.0%$245K+122bp9mo
Clean Claim Rate88.0%96.0%$13K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$422K
Cost to Collect
$402K
Denial Rate Reduction
$398K
A/R Days Reduction
$245K
Clean Claim Rate
$13K
Total EBITDA Uplift$1.5M
Current EBITDA$-1.9M
+ RCM Uplift+$1.5M
Pro Forma EBITDA$-384K
Current Margin-9.3%
Pro Forma Margin-1.9%
WC Released (1x)$772K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-2.9M$2.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-2.9M$1.8M0.00x-100.0%
Bull Case9.0x11.0x$-2.6M$5.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-2.6M$5.5M0.00x-100.0%
Bear Case11.0x10.0x$-3.2M$-4.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-3.2M$-5.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 27.9%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 55.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 39 hospitals with 12-46 beds
  • Same-state prioritization (n=40)
  • Comp margins: P25=-15.7% / P50=-9.8% / P75=-4.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.